| Diagnostic and prognostic epigenetic biomarkers in cancer P Costa-Pinheiro, D Montezuma, R Henrique, C Jerónimo Epigenomics 7 (6), 1003-1015, 2015 | 231 | 2015 |
| Deregulated expression of selected histone methylases and demethylases in prostate carcinoma FQ Vieira, P Costa-Pinheiro, J Ramalho-Carvalho, A Pereira, ... Endocrine-related cancer 21 (1), 51-61, 2014 | 108 | 2014 |
| MicroRNA-375 plays a dual role in prostate carcinogenesis P Costa-Pinheiro, J Ramalho-Carvalho, FQ Vieira, J Torres-Ferreira, ... Clinical epigenetics 7, 1-14, 2015 | 105 | 2015 |
| MicroRNA profile: a promising ancillary tool for accurate renal cell tumour diagnosis RM Silva-Santos, P Costa-Pinheiro, A Luis, L Antunes, F Lobo, J Oliveira, ... British journal of cancer 109 (10), 2646-2653, 2013 | 98 | 2013 |
| SMYD3 contributes to a more aggressive phenotype of prostate cancer and targets Cyclin D2 through H4K20me3 FQ Vieira, P Costa-Pinheiro, D Almeida-Rios, I Graça, S Monteiro-Reis, ... Oncotarget 6 (15), 13644, 2015 | 85 | 2015 |
| Anti-neoplastic properties of hydralazine in prostate cancer I Graça, EJ Sousa, P Costa-Pinheiro, FQ Vieira, J Torres-Ferreira, ... Oncotarget 5 (15), 5950, 2014 | 70 | 2014 |
| Epigenetic disruption of miR-130a promotes prostate cancer by targeting SEC23B and DEPDC1 J Ramalho-Carvalho, JB Martins, L Cekaite, A Sveen, J Torres-Ferreira, ... Cancer letters 385, 150-159, 2017 | 68 | 2017 |
| Expression of histone methyltransferases as novel biomarkers for renal cell tumor diagnosis and prognostication AS Pires-Luís, M Vieira-Coimbra, FQ Vieira, P Costa-Pinheiro, ... Epigenetics 10 (11), 1033-1043, 2015 | 67 | 2015 |
| Regulation of histone H2A. Z expression is mediated by sirtuin 1 in prostate cancer T Baptista, I Graca, EJ Sousa, AI Oliveira, NR Costa, P Costa-Pinheiro, ... Oncotarget 4 (10), 1673, 2013 | 62 | 2013 |
| MicroRNA-27a-5p regulation by promoter methylation and MYC signaling in prostate carcinogenesis D Barros-Silva, P Costa-Pinheiro, H Duarte, EJ Sousa, AF Evangelista, ... Cell death & disease 9 (2), 167, 2018 | 60 | 2018 |
| Novel sphingolipid-based cancer therapeutics in the personalized medicine era J Shaw, P Costa-Pinheiro, L Patterson, K Drews, S Spiegel, M Kester Advances in cancer research 140, 327-366, 2018 | 58 | 2018 |
| Glucosylceramidase maintains influenza virus infection by regulating endocytosis K Drews, MP Calgi, WC Harrison, CM Drews, P Costa-Pinheiro, JJP Shaw, ... Journal of virology 93 (12), 10.1128/jvi. 00017-19, 2019 | 50 | 2019 |
| Comparing diagnostic and prognostic performance of two-gene promoter methylation panels in tissue biopsies and urines of prostate cancer patients C Moreira-Barbosa, D Barros-Silva, P Costa-Pinheiro, J Torres-Ferreira, ... Clinical Epigenetics 10, 1-11, 2018 | 34 | 2018 |
| Glucosylceramide production maintains colon integrity in response to Bacteroides fragilis toxin-induced colon epithelial cell signaling L Patterson, J Allen, I Posey, JJP Shaw, P Costa-Pinheiro, SJ Walker, ... FASEB journal: official publication of the Federation of American Societies …, 2020 | 29 | 2020 |
| Glucosylceramide synthase maintains influenza virus entry and infection K Drews, MP Calgi, WC Harrison, CM Drews, P Costa-Pinheiro, JJP Shaw, ... PloS one 15 (2), e0228735, 2020 | 29 | 2020 |
| Deregulation of PAX 2 expression in renal cell tumours: mechanisms and potential use in differential diagnosis P Patrício, J Ramalho‐Carvalho, P Costa‐Pinheiro, M Almeida, ... Journal of Cellular and Molecular Medicine 17 (8), 1048-1058, 2013 | 26 | 2013 |
| Identification of clear cell renal cell carcinoma and oncocytoma using a three-gene promoter methylation panel AS Pires-Luís, P Costa-Pinheiro, MJ Ferreira, L Antunes, F Lobo, ... Journal of translational medicine 15, 1-9, 2017 | 25 | 2017 |
| SETDB2 and RIOX2 are differentially expressed among renal cell tumor subtypes, associating with prognosis and metastization MJ Ferreira, AS Pires-Luis, M Vieira-Coimbra, P Costa-Pinheiro, ... Epigenetics 12 (12), 1057-1064, 2017 | 22 | 2017 |
| Biomarkers and personalized risk stratification for patients with clinically localized prostate cancer P Costa-Pinheiro, HRH Patel, R Henrique, C Jeronimo Expert Review of Anticancer Therapy 14 (11), 1349-1358, 2014 | 15 | 2014 |
| Inhibition of lysosomal function mitigates protective mitophagy and augments ceramide nanoliposome–induced cell death in head and neck squamous cell carcinoma JJP Shaw, TL Boyer, E Venner, PJ Beck, T Slamowitz, T Caste, ... Molecular cancer therapeutics 19 (12), 2621-2633, 2020 | 12 | 2020 |
Carmen JeronimoPortuguese Oncology Institute of Porto在 ipoporto.min-saude.pt 的电子邮件经过验证
